The Trump administration will pay nearly $2 billion to Pfizer for 100 million doses of a COVID-19 vaccine it's developing with another company.
In Connecticut on Wednesday, the pharmaceutical company gave an update on how soon that could happen; CBS2's Alice Gainer reports.